HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hideichi Makino Selected Research

Resistin

10/2010Circulating resistin is increased with decreasing renal function in a general Japanese population: the Hisayama Study.
3/2010A at single nucleotide polymorphism-358 is required for G at -420 to confer the highest plasma resistin in the general Japanese population.
11/2009Diabetes and hypertension markedly increased the risk of ischemic stroke associated with high serum resistin concentration in a general Japanese population: the Hisayama Study.
9/2009PPARgamma Pro12Ala Pro/Pro and resistin SNP-420 G/G genotypes are synergistically associated with plasma resistin in the Japanese general population.
1/2009A pilot study suggests that the G/G genotype of resistin single nucleotide polymorphism at -420 may be an independent predictor of a reduction in fasting plasma glucose and insulin resistance by pioglitazone in type 2 diabetes.
8/2008[Role of resistin in insulin resistance].
7/2008Serum resistin is positively correlated with the accumulation of metabolic syndrome factors in type 2 diabetes.
2/2008Resistin, glomerular filtration rate, and insulin resistance.
2/2008Hyperresistinemia is associated with coexistence of hypertension and type 2 diabetes.
2/2008Serum resistin is reduced by glucose and meal loading in healthy human subjects.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hideichi Makino Research Topics

Disease

25Type 2 Diabetes Mellitus (MODY)
01/2022 - 03/2002
23Insulin Resistance
10/2010 - 03/2002
14Type 1 Diabetes Mellitus (Autoimmune Diabetes)
03/2022 - 06/2002
7Hypertension (High Blood Pressure)
10/2010 - 09/2003
5Atherosclerosis
07/2008 - 06/2006
4Hyperlipidemias (Hyperlipidemia)
08/2007 - 09/2003
3Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2008 - 02/2008
3Obesity
07/2008 - 09/2003
2Glucose Intolerance
01/2022 - 12/2012
2Hypersensitivity (Allergy)
09/2014 - 02/2008
2Diabetic Ketoacidosis (Ketoacidosis, Diabetic)
02/2014 - 01/2008
2Ketosis
02/2014 - 01/2008
2Diabetic Angiopathies (Diabetic Angiopathy)
03/2008 - 04/2007
2Diabetes Mellitus
11/2007 - 01/2005
1Hypoglycemia (Reactive Hypoglycemia)
03/2022
1Amyloid Plaque
07/2018
1Liver Diseases (Liver Disease)
06/2014
1Hyperglycemia
02/2012
1Autoimmune Diseases (Autoimmune Disease)
09/2011
1Chronic Renal Insufficiency
10/2010
1Renal Insufficiency (Renal Failure)
10/2010
1Heart Failure
01/2010
1Ischemic Stroke
11/2009
1Hemorrhagic Stroke
11/2009
1Cardiovascular Diseases (Cardiovascular Disease)
11/2009
1Coronary Artery Disease (Coronary Atherosclerosis)
11/2009
1Coronary Disease (Coronary Heart Disease)
11/2009
1Infarction (Infarctions)
11/2009
1Latent Autoimmune Diabetes in Adults
04/2008
1Diabetic Retinopathy (Retinopathy, Diabetic)
03/2008
1Diabetic Neuropathies (Diabetic Neuropathy)
02/2008
1Disease Progression
02/2008
1Fatty Liver
01/2008
1Type 2 Hdl Deficiency
06/2007
1Panniculitis
06/2007
1Neoplasms (Cancer)
06/2007
1Inflammation (Inflammations)
06/2007
1Hypotension (Low Blood Pressure)
06/2007
1Fibrosis (Cirrhosis)
06/2007

Drug/Important Bio-Agent (IBA)

19ResistinIBA
10/2010 - 03/2002
17Insulin (Novolin)FDA Link
03/2022 - 03/2002
7Glucose (Dextrose)FDA LinkGeneric
01/2022 - 05/2007
5AutoantibodiesIBA
09/2014 - 08/2003
4C-Reactive ProteinIBA
10/2010 - 06/2007
4AdiponectinIBA
03/2008 - 05/2007
3HLA-DR Antigens (HLA-DR)IBA
09/2011 - 10/2004
3Triglycerides (Triacylglycerol)IBA
10/2010 - 07/2008
3HDL CholesterolIBA
08/2008 - 06/2007
2Islet Amyloid PolypeptideIBA
10/2018 - 07/2018
2C-PeptideIBA
02/2014 - 04/2008
2Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
12/2012 - 01/2005
2AntibodiesIBA
02/2012 - 08/2003
2HLA-DRB1 Chains (HLA DRB1)IBA
02/2012 - 06/2002
2Insulin Receptor Substrate ProteinsIBA
07/2008 - 11/2002
2CytokinesIBA
02/2008 - 11/2007
2Transcription Factors (Transcription Factor)IBA
01/2008 - 02/2003
2oxidized low density lipoproteinIBA
08/2007 - 04/2007
2Type 3 Cyclic Nucleotide PhosphodiesterasesIBA
09/2003 - 05/2003
1Insulin AntibodiesIBA
03/2022
1Amyloid (Amyloid Fibrils)IBA
07/2018
1Rocuronium (Zemuron)FDA LinkGeneric
06/2014
1Remifentanil (Ultiva)FDA Link
06/2014
1Propofol (Diprivan)FDA LinkGeneric
06/2014
1SugammadexIBA
06/2014
1HLA Antigens (Human Leukocyte Antigens)IBA
12/2012
1Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
02/2012
1Ribavirin (Virazole)FDA LinkGeneric
09/2011
1HLA-DR13 antigenIBA
09/2011
1Antiviral Agents (Antivirals)IBA
09/2011
1InterferonsIBA
09/2011
1CholesterolIBA
10/2010
1HDL LipoproteinsIBA
10/2010
1DiureticsIBA
01/2010
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2010
1PPAR gammaIBA
09/2009
1Pioglitazone (Actos)FDA Link
01/2009
1HLA-DR4 Antigen (HLA DR4 Antigen)IBA
08/2008
1MitogensIBA
07/2008
1Phosphotransferases (Kinase)IBA
07/2008
1Serine (L-Serine)FDA Link
07/2008
1Mitogen-Activated Protein Kinase 8IBA
07/2008
1Iodide Peroxidase (Deiodinase)IBA
04/2008
1ICA512 autoantibodyIBA
04/2008
1CreatinineIBA
03/2008
1Fatty Acid-Binding ProteinsIBA
02/2008
1Antihypertensive Agents (Antihypertensives)IBA
02/2008
1AdipokinesIBA
02/2008
1EnzymesIBA
01/2008
1Transaminases (Aminotransferases)IBA
01/2008
1Blood Glucose (Blood Sugar)IBA
01/2008
1Protein Tyrosine PhosphatasesIBA
11/2007
1Advanced Glycation End ProductsIBA
11/2007
1Indicators and Reagents (Reagents)IBA
08/2007
1LDL CholesterolIBA
08/2007
1CollagenIBA
06/2007
1LeptinIBA
05/2007

Therapy/Procedure

3Therapeutics
09/2011 - 01/2008
3Glycemic Control
01/2009 - 08/2007
1Anesthesia
06/2014
1Intravenous Administration
01/2010